Insider · CIK 0001861477

Thompson Elizabeth H.Z.

Reports to the SEC for 3 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001861477

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-30	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, Head of Research & Dev	SSale	−16.5K sh	$26.13	−$431K	19,044
2026-07-30	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, Head of Research & Dev	SSale	−50 sh	$26.17	−$1,308.5	18,994
2026-07-29	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, Head of Research & Dev	MExercise/Conversion	+32.3K sh	—	—	35,552
2026-07-29	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of Research & Dev	MExercise/Conversion	−32.3K sh	—	—	32,272
2026-03-25	ACADACADIA PHARMACEUTICALS INCS Sale	EVP, Head of Research & Dev	SSale	−3,435 sh	$21.47	−$73.7K	3,280
2026-03-24	ACADACADIA PHARMACEUTICALS INCM Exercise/Conversion	EVP, Head of Research & Dev	MExercise/Conversion	+6,715 sh	—	—	6,715
2026-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsM Exercise/Conversion	EVP, Head of Research & Dev	MExercise/Conversion	−6,715 sh	—	—	20,146
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Head of Research & Dev	AAward	+102K sh	—	—	101,574
2026-03-06	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, Head of Research & Dev	AAward	+29.5K sh	—	—	29,548
2025-08-14	IGM Biosciences, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7,196 sh	—	—	0
2025-06-30	IGM Biosciences, Inc.A Award	Director	AAward	+694 sh	—	—	7,196
2025-03-31	IGM Biosciences, Inc.A Award	Director	AAward	+694 sh	—	—	6,502
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Head of Research & Dev	AAward	+91.4K sh	—	—	91,395
2025-03-24	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, Head of Research & Dev	AAward	+26.9K sh	—	—	26,861
2024-12-31	IGM Biosciences, Inc.A Award	Director	AAward	+1,452 sh	—	—	5,808
2024-09-30	IGM Biosciences, Inc.A Award	Director	AAward	+1,452 sh	—	—	4,356
2024-08-12	ACADACADIA PHARMACEUTICALS INC · Stock Option (Right to Buy)A Award	EVP, Head of Research & Dev	AAward	+325K sh	—	—	324,582
2024-08-12	ACADACADIA PHARMACEUTICALS INC · Restricted Stock UnitsA Award	EVP, Head of Research & Dev	AAward	+64.5K sh	—	—	64,544
2024-06-28	IGM Biosciences, Inc.A Award	Director	AAward	+1,452 sh	—	—	2,904
2024-03-29	IGM Biosciences, Inc.A Award	Director	AAward	+1,452 sh	—	—	1,452
2024-03-12	IGM Biosciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+29.4K sh	—	—	29,400
2023-10-06	Horizon Therapeutics Public Ltd CoD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−14.6K sh	$116.50	−$1.7M	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−4,657 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−14.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoRestricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−20.7K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−4,285 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−12.9K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−21.4K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−10.3K sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−5,174 sh	—	—	0
2023-10-06	Horizon Therapeutics Public Ltd CoPerformance Restricted Stock UnitsD Disposition to Issuer	EVP, Research & Development	DDisposition to Issuer	−5,174 sh	—	—	0
2023-10-03	IGM Biosciences, Inc.Stock Option (right to buy)A Award	Director	AAward	+31K sh	—	—	31,000
2023-03-13	Horizon Therapeutics Public Ltd CoG Gift	EVP, Research & Development	GGift	−2,000 sh	—	—	14,575
2023-01-04	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP, Research & Development	AAward	+20.7K sh	—	—	20,697
2022-12-30	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	+19.1K sh	—	—	26,024
2022-12-30	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Research & Development	FTax Payment	−9,449 sh	$113.80	−$1.08M	16,575
2022-12-30	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	−7,257 sh	—	—	0
2022-12-30	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	−4,657 sh	—	—	4,657
2022-12-30	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	−7,141 sh	—	—	14,283
2022-07-20	Horizon Therapeutics Public Ltd CoS Sale	EVP, Research & Development	SSale	−5,917 sh	$85.00	−$503K	6,969
2022-07-19	Horizon Therapeutics Public Ltd CoS Sale	EVP, Research & Development	SSale	−8 sh	$85.02	−$680.12	12,968
2022-07-19	Horizon Therapeutics Public Ltd CoS Sale	EVP, Research & Development	SSale	−82 sh	$85.04	−$6,973.28	12,886
2022-07-07	Horizon Therapeutics Public Ltd CoS Sale	EVP, Research & Development	SSale	−82 sh	$85.01	−$6,970.82	12,976
2022-04-18	Horizon Therapeutics Public Ltd CoS Sale	EVP, Research & Development	SSale	−8,098 sh	$115.64	−$936K	13,058
2022-01-05	Horizon Therapeutics Public Ltd CoM Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	+14K sh	—	—	28,186
2022-01-05	Horizon Therapeutics Public Ltd CoF Tax Payment	EVP, Research & Development	FTax Payment	−7,030 sh	$101.84	−$716K	21,156
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	−2,085 sh	—	—	0
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	−7,257 sh	—	—	7,257
2022-01-05	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)M Exercise/Conversion	EVP, Research & Development	MExercise/Conversion	−4,657 sh	—	—	9,314
2022-01-04	Horizon Therapeutics Public Ltd CoRestricted Stock Units (RSU)A Award	EVP, Research & Development	AAward	+21.4K sh	—	—	21,424

Recent filings

Accepted (ET)
Jul 314
Thompson Elizabeth H.Z.0001861477-26-000005
SEC(opens sec.gov)
Mar 264
Thompson Elizabeth H.Z.0001861477-26-000003
SEC(opens sec.gov)
Mar 104
Thompson Elizabeth H.Z.0001861477-26-000002
SEC(opens sec.gov)
Aug 144
Thompson Elizabeth H.Z.0001415889-25-021961
SEC(opens sec.gov)
Jul 24
Thompson Elizabeth H.Z.0001415889-25-019153
SEC(opens sec.gov)
Apr 24
Thompson Elizabeth H.Z.0001415889-25-009778
SEC(opens sec.gov)
Mar 264
Thompson Elizabeth H.Z.0001415889-25-009068
SEC(opens sec.gov)
Jan 34
Thompson Elizabeth H.Z.0001415889-25-000609
SEC(opens sec.gov)
Oct 24
Thompson Elizabeth H.Z.0001415889-24-024534
SEC(opens sec.gov)
Aug 134
Thompson Elizabeth H.Z.0001415889-24-021243
SEC(opens sec.gov)
Jul 24
Thompson Elizabeth H.Z.0001415889-24-019057
SEC(opens sec.gov)
Apr 24
Thompson Elizabeth H.Z.0001415889-24-009851
SEC(opens sec.gov)

Companies

Address

C/O ACADIA PHARMACEUTICALS INC. 12830 EL CAMINO REAL, SUITE 400

SAN DIEGO, CA, 92130